AMESOL

This brand name is authorized in Cyprus, Hong Kong, Malta

Active ingredients

The drug AMESOL contains one active pharmaceutical ingredient (API):

1 Levofloxacin
UNII 6GNT3Y5LMF - LEVOFLOXACIN

Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.

Read about Levofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AMESOL Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01MA12 Levofloxacin J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 66425, 66426
Country: MT Medicines Authority Identifier(s): AA032/09101

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.